ALMR is Alamar Biosciences, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $30.80. Market cap: $2.14B.
Stock snapshot
| Price | $30.80 |
| Market cap | $2.14B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About ALMR
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Related non-dividend companies
Other non-dividend stocks investors research alongside ALMR. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ALMR's current stock price?
ALMR (Alamar Biosciences, Inc.) is currently trading at $30.80.
Does ALMR pay a dividend?
ALMR (Alamar Biosciences, Inc.) does not currently pay a regular dividend.
Track ALMR in DiviDrip
Add ALMR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ALMR and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.